Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.
Published May 28, 2014 · Recall initiated: April 22, 2014
Summary
FDA records drug Class II recall D-1344-2014, published May 28, 2014 and initiated April 22, 2014. Recalling firm: SigmaPharm Laboratories LLC; Status: Terminated; Reported quantity: 43,007 Bottles; Lot: Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
What to do
Voluntary: Firm initiated · Letter
Get an email if LIOTHYRONINE SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LIOTHYRONINE SODIUM
- Manufacturer
- SigmaPharm Laboratories LLC
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0342794018121
- Lot
- Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALiothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun PharmaceuticalDecember 20, 2023
- FDALiothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun PharmaceuticalNovember 8, 2023
- FDALiothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun PharmaceuticalNovember 8, 2023
- FDAphosLo (calcium acetate) GelCaps, 667 mg, 200-count bottle, Rx only, Manufactured for Fresenius Medical CareMay 28, 2014
- FDAP-BOOST Capsules Dietary Supplement 500 mg, supplied in 1 count blister pack and 5, 10, 20, and 40- countMay 28, 2014
- FDAPROMETHAZINE HYDROCHLORIDE Tablets, USP, 25 mg, 100 Tablet Bottles, Rx Only. Manufactured by: CadilaMay 28, 2014
Questions about this recall
Was Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa. recalled?
Yes. FDA published recall D-1344-2014 on May 28, 2014. Reported hazard: Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LIOTHYRONINE SODIUM. UPC: 0342794018121.